Sociodemographic and Clinical-pathological Study of Molecular Subtitles of Breast Carcinoma in a Reference Unit of Maranhão

• Published in: Revista Brasileira de ginecologia e obstetrícia 2020-12, Vol.42 (12), p.820-828
• Main Authors: Reis, Ana Paula Almeida Miranda, Teixeira, Cecilma Miranda de Sousa, Medeiros, Adriano Rêgo Lima de, Chaves, Karlla Zolinda Cantão, Albuquerque, Camila Rosa de, Melo, Mateus Rufino
• Format: Article
• Language: English
• Subjects: Brazil - epidemiology; breast neoplasms; Breast Neoplasms - epidemiology; Breast Neoplasms - etiology; Breast Neoplasms - pathology; Cross-Sectional Studies; Demography; Female; health profile; Humans; Immunohistochemistry; Mastectomy; Medical Records; Middle Aged; OBSTETRICS & GYNECOLOGY; oncology; Original; Receptors, Estrogen - metabolism; Retrospective Studies; Social Class; staging of neoplasms
• ISSN: 0100-7203; 1806-9339; 1806-9339
• DOI: 10.1055/s-0040-1719147

To evaluate the distribution of the main sociodemographic and clinical-pathological characteristics in women with breast cancer according to the molecular profile by immunohistochemistry.  A cross-sectional, retrospective, analytical and quantitative study was performed, with an analysis of 137 medical records from January 2015 to December 2018 of women attending the High Complexity in Oncology Unit of the city of Imperatriz, state of Maranhão, Brazil. The immunohistochemical profile of tumors based on the estrogen and progesterone receptor, Human Epidermal growth factor Receptor-type 2 (HER2) overexpression and Ki67 cell proliferation index was defined, from which six molecular subtypes were determined: luminal A, luminal B-HER2 negative, luminal B-HER2 positive, triple negative, overexpression of HER2 and inconclusive.  A total of 52.6% of the patients were postmenopausal, mean age 52.1 years old, brown (56.2%), had a schooling level  IIB (52.6%) and 23.4% had metastasis. Invasive ductal carcinoma accounted for 84.7%, tumor size was 2 to 5 cm (48.9%), with lymph node involvement (56.2%), axillary lymphadenectomy in 67.2%, and mastectomy in 73.7% of the patients. The most frequent molecular subtype was the luminal B-HER2 negative (36.5%), and the luminal A subtype showed characteristics of better prognosis when compared with the others.  It was concluded that in the association of molecular subtypes with sociodemographic and clinical-pathological characteristics, there were no statistically significant results obtained, except for complementary therapy, referring to hormone therapy, and there was a high index of metastasis at diagnosis, which was a worrying factor and indicative of failures in the screening and early diagnosis of this population.